Report Detail

Request for Sample of this report

Service & Software Global AI in Respiratory Diseases Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4573061
    • |
  • 02 January, 2024
    • |
  • Global
    • |
  • 130 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global AI in Respiratory Diseases market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the AI in Respiratory Diseases industry chain, the market status of Hospital (Pulmonary Infection, MRI), Diagnostic Centers (Pulmonary Infection, MRI), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of AI in Respiratory Diseases.
Regionally, the report analyzes the AI in Respiratory Diseases markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global AI in Respiratory Diseases market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the AI in Respiratory Diseases market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the AI in Respiratory Diseases industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Pulmonary Infection, MRI).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the AI in Respiratory Diseases market.
Regional Analysis: The report involves examining the AI in Respiratory Diseases market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the AI in Respiratory Diseases market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to AI in Respiratory Diseases:
Company Analysis: Report covers individual AI in Respiratory Diseases players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards AI in Respiratory Diseases This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Diagnostic Centers).
Technology Analysis: Report covers specific technologies relevant to AI in Respiratory Diseases. It assesses the current state, advancements, and potential future developments in AI in Respiratory Diseases areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the AI in Respiratory Diseases market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
AI in Respiratory Diseases market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Pulmonary Infection
MRI
CT Scan
Market segment by Application
Hospital
Diagnostic Centers
Ambulatory Surgical Centers
Others
Market segment by players, this report covers
ArtiQ
Philips Healthcare
GE Healthcare
Siemens Healthineers
Swaasa AI
THIRONA
DeepMind Health
Verily
VIDA Diagnostics Inc
Icometrix
Infervision
PneumoWave
Respiray
Dectrocel Healthcare
Zynnon
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI in Respiratory Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI in Respiratory Diseases, with revenue, gross margin and global market share of AI in Respiratory Diseases from 2018 to 2023.
Chapter 3, the AI in Respiratory Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and AI in Respiratory Diseases market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI in Respiratory Diseases.
Chapter 13, to describe AI in Respiratory Diseases research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of AI in Respiratory Diseases
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI in Respiratory Diseases by Type
    • 1.3.1 Overview: Global AI in Respiratory Diseases Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global AI in Respiratory Diseases Consumption Value Market Share by Type in 2022
    • 1.3.3 Pulmonary Infection
    • 1.3.4 MRI
    • 1.3.5 CT Scan
  • 1.4 Global AI in Respiratory Diseases Market by Application
    • 1.4.1 Overview: Global AI in Respiratory Diseases Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Diagnostic Centers
    • 1.4.4 Ambulatory Surgical Centers
    • 1.4.5 Others
  • 1.5 Global AI in Respiratory Diseases Market Size & Forecast
  • 1.6 Global AI in Respiratory Diseases Market Size and Forecast by Region
    • 1.6.1 Global AI in Respiratory Diseases Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global AI in Respiratory Diseases Market Size by Region, (2018-2029)
    • 1.6.3 North America AI in Respiratory Diseases Market Size and Prospect (2018-2029)
    • 1.6.4 Europe AI in Respiratory Diseases Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific AI in Respiratory Diseases Market Size and Prospect (2018-2029)
    • 1.6.6 South America AI in Respiratory Diseases Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa AI in Respiratory Diseases Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 ArtiQ
    • 2.1.1 ArtiQ Details
    • 2.1.2 ArtiQ Major Business
    • 2.1.3 ArtiQ AI in Respiratory Diseases Product and Solutions
    • 2.1.4 ArtiQ AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 ArtiQ Recent Developments and Future Plans
  • 2.2 Philips Healthcare
    • 2.2.1 Philips Healthcare Details
    • 2.2.2 Philips Healthcare Major Business
    • 2.2.3 Philips Healthcare AI in Respiratory Diseases Product and Solutions
    • 2.2.4 Philips Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Philips Healthcare Recent Developments and Future Plans
  • 2.3 GE Healthcare
    • 2.3.1 GE Healthcare Details
    • 2.3.2 GE Healthcare Major Business
    • 2.3.3 GE Healthcare AI in Respiratory Diseases Product and Solutions
    • 2.3.4 GE Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 GE Healthcare Recent Developments and Future Plans
  • 2.4 Siemens Healthineers
    • 2.4.1 Siemens Healthineers Details
    • 2.4.2 Siemens Healthineers Major Business
    • 2.4.3 Siemens Healthineers AI in Respiratory Diseases Product and Solutions
    • 2.4.4 Siemens Healthineers AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Siemens Healthineers Recent Developments and Future Plans
  • 2.5 Swaasa AI
    • 2.5.1 Swaasa AI Details
    • 2.5.2 Swaasa AI Major Business
    • 2.5.3 Swaasa AI AI in Respiratory Diseases Product and Solutions
    • 2.5.4 Swaasa AI AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Swaasa AI Recent Developments and Future Plans
  • 2.6 THIRONA
    • 2.6.1 THIRONA Details
    • 2.6.2 THIRONA Major Business
    • 2.6.3 THIRONA AI in Respiratory Diseases Product and Solutions
    • 2.6.4 THIRONA AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 THIRONA Recent Developments and Future Plans
  • 2.7 DeepMind Health
    • 2.7.1 DeepMind Health Details
    • 2.7.2 DeepMind Health Major Business
    • 2.7.3 DeepMind Health AI in Respiratory Diseases Product and Solutions
    • 2.7.4 DeepMind Health AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 DeepMind Health Recent Developments and Future Plans
  • 2.8 Verily
    • 2.8.1 Verily Details
    • 2.8.2 Verily Major Business
    • 2.8.3 Verily AI in Respiratory Diseases Product and Solutions
    • 2.8.4 Verily AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Verily Recent Developments and Future Plans
  • 2.9 VIDA Diagnostics Inc
    • 2.9.1 VIDA Diagnostics Inc Details
    • 2.9.2 VIDA Diagnostics Inc Major Business
    • 2.9.3 VIDA Diagnostics Inc AI in Respiratory Diseases Product and Solutions
    • 2.9.4 VIDA Diagnostics Inc AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 VIDA Diagnostics Inc Recent Developments and Future Plans
  • 2.10 Icometrix
    • 2.10.1 Icometrix Details
    • 2.10.2 Icometrix Major Business
    • 2.10.3 Icometrix AI in Respiratory Diseases Product and Solutions
    • 2.10.4 Icometrix AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Icometrix Recent Developments and Future Plans
  • 2.11 Infervision
    • 2.11.1 Infervision Details
    • 2.11.2 Infervision Major Business
    • 2.11.3 Infervision AI in Respiratory Diseases Product and Solutions
    • 2.11.4 Infervision AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Infervision Recent Developments and Future Plans
  • 2.12 PneumoWave
    • 2.12.1 PneumoWave Details
    • 2.12.2 PneumoWave Major Business
    • 2.12.3 PneumoWave AI in Respiratory Diseases Product and Solutions
    • 2.12.4 PneumoWave AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 PneumoWave Recent Developments and Future Plans
  • 2.13 Respiray
    • 2.13.1 Respiray Details
    • 2.13.2 Respiray Major Business
    • 2.13.3 Respiray AI in Respiratory Diseases Product and Solutions
    • 2.13.4 Respiray AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Respiray Recent Developments and Future Plans
  • 2.14 Dectrocel Healthcare
    • 2.14.1 Dectrocel Healthcare Details
    • 2.14.2 Dectrocel Healthcare Major Business
    • 2.14.3 Dectrocel Healthcare AI in Respiratory Diseases Product and Solutions
    • 2.14.4 Dectrocel Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Dectrocel Healthcare Recent Developments and Future Plans
  • 2.15 Zynnon
    • 2.15.1 Zynnon Details
    • 2.15.2 Zynnon Major Business
    • 2.15.3 Zynnon AI in Respiratory Diseases Product and Solutions
    • 2.15.4 Zynnon AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Zynnon Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI in Respiratory Diseases Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of AI in Respiratory Diseases by Company Revenue
    • 3.2.2 Top 3 AI in Respiratory Diseases Players Market Share in 2022
    • 3.2.3 Top 6 AI in Respiratory Diseases Players Market Share in 2022
  • 3.3 AI in Respiratory Diseases Market: Overall Company Footprint Analysis
    • 3.3.1 AI in Respiratory Diseases Market: Region Footprint
    • 3.3.2 AI in Respiratory Diseases Market: Company Product Type Footprint
    • 3.3.3 AI in Respiratory Diseases Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI in Respiratory Diseases Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global AI in Respiratory Diseases Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global AI in Respiratory Diseases Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global AI in Respiratory Diseases Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America AI in Respiratory Diseases Consumption Value by Type (2018-2029)
  • 6.2 North America AI in Respiratory Diseases Consumption Value by Application (2018-2029)
  • 6.3 North America AI in Respiratory Diseases Market Size by Country
    • 6.3.1 North America AI in Respiratory Diseases Consumption Value by Country (2018-2029)
    • 6.3.2 United States AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 6.3.3 Canada AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico AI in Respiratory Diseases Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe AI in Respiratory Diseases Consumption Value by Type (2018-2029)
  • 7.2 Europe AI in Respiratory Diseases Consumption Value by Application (2018-2029)
  • 7.3 Europe AI in Respiratory Diseases Market Size by Country
    • 7.3.1 Europe AI in Respiratory Diseases Consumption Value by Country (2018-2029)
    • 7.3.2 Germany AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 7.3.3 France AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 7.3.5 Russia AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 7.3.6 Italy AI in Respiratory Diseases Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI in Respiratory Diseases Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific AI in Respiratory Diseases Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific AI in Respiratory Diseases Market Size by Region
    • 8.3.1 Asia-Pacific AI in Respiratory Diseases Consumption Value by Region (2018-2029)
    • 8.3.2 China AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 8.3.3 Japan AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 8.3.5 India AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 8.3.7 Australia AI in Respiratory Diseases Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America AI in Respiratory Diseases Consumption Value by Type (2018-2029)
  • 9.2 South America AI in Respiratory Diseases Consumption Value by Application (2018-2029)
  • 9.3 South America AI in Respiratory Diseases Market Size by Country
    • 9.3.1 South America AI in Respiratory Diseases Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina AI in Respiratory Diseases Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI in Respiratory Diseases Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa AI in Respiratory Diseases Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa AI in Respiratory Diseases Market Size by Country
    • 10.3.1 Middle East & Africa AI in Respiratory Diseases Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia AI in Respiratory Diseases Market Size and Forecast (2018-2029)
    • 10.3.4 UAE AI in Respiratory Diseases Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 AI in Respiratory Diseases Market Drivers
  • 11.2 AI in Respiratory Diseases Market Restraints
  • 11.3 AI in Respiratory Diseases Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AI in Respiratory Diseases Industry Chain
  • 12.2 AI in Respiratory Diseases Upstream Analysis
  • 12.3 AI in Respiratory Diseases Midstream Analysis
  • 12.4 AI in Respiratory Diseases Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on AI in Respiratory Diseases. Industry analysis & Market Report on AI in Respiratory Diseases is a syndicated market report, published as Global AI in Respiratory Diseases Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of AI in Respiratory Diseases market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,648.28
    		3,972.42
    		5,296.56
    		3,138.96
    		4,708.44
    		6,277.92
    		496,282.80
    		744,424.20
    		992,565.60
    		292,250.40
    		438,375.60
    		584,500.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo